Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyMadeleine Scott, Purvesh Khatri, Jonathan A. Kropski et al.|The Lancet Respiratory Medicine|2019Cited by 249
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyJose D. Herazo‐Maya, Naftali Kaminski, Erica L. Herzog et al.|The Lancet Respiratory Medicine|2017Cited by 191
50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort studyBrenda M. Juan Guardela, Jose D. Herazo‐Maya, Jiehuan Sun et al.|EBioMedicine|2021Cited by 46